Thoracic mesenchymal malignant tumors and programed cell death ligand ‐1 status: Clinicopathologic and prognostic analysis of eight pulmonary sarcomatoid carcinomas and eightmalignant mesotheliomas
ConclusionThe present study showed that sarcomatoid carcinoma had a higher PD-L1 expression compared to non-small-cell lung cancer and that both PSC and MPM tended to exhibit PD-L1 positivity in the sarcomatoid compartment. Moreover, while immune checkpoint inhibitors may somewhat prolong the prognosis of both tumors, further studies with a larger cohort are necessary to confirm our results.
Source: Thoracic Cancer - Category: Cancer & Oncology Authors: Kanji Otsubo,
Hiroki Sakai,
Hiroyuki Kimura,
Tomoyuki Miyazawa,
Hideki Marushima,
Koji Kojima,
Naoki Furuya,
Masamichi Mineshita,
Motohiro Chosokabe,
Junki Koike,
Hisashi Saji Tags: ORIGINAL ARTICLE Source Type: research
More News: Asbestosis | Cancer | Cancer & Oncology | Carcinoma | Lung Cancer | Mesothelioma | Non-Small Cell Lung Cancer | Study